AMPHOTERICIN B DERIVATIVES WITH IMPROVED THERAPEUTIC INDEX

6 ABTRACT Provided are certain derivatives of amphotericin B (AmB) characterized by reduced toxicity and retained anti-fungal activity. Certain of the derivatives are C16 urea derivatives of AmB. Certain of the derivatives are C3, C5, C8, C9, C11, C13, or C15 deoxy derivatives of AmB. Certain of the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: UNO, BRICE E, STRUBLE, JUSTIN, DAILEY, IAN, KNAPP, DAVID M, PALYAM, NAGARJUNA, BURKE, MARTIN D, DAVIS, STEPHEN, GRAY, KAITLYN C, WANG, PULIN
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator UNO, BRICE E
STRUBLE, JUSTIN
DAILEY, IAN
KNAPP, DAVID M
PALYAM, NAGARJUNA
BURKE, MARTIN D
DAVIS, STEPHEN
GRAY, KAITLYN C
WANG, PULIN
description 6 ABTRACT Provided are certain derivatives of amphotericin B (AmB) characterized by reduced toxicity and retained anti-fungal activity. Certain of the derivatives are C16 urea derivatives of AmB. Certain of the derivatives are C3, C5, C8, C9, C11, C13, or C15 deoxy derivatives of AmB. Certain of the derivatives include C3' or C4 modifications of the mycosamine appendage of AmB. Also provided are methods of making AmB derivatives of the invention, pharmaceutical compositions comprising AmB derivatives of the invention, and methods of use of AmB derivatives of the invention. OH OH \ 0 HO /Me 0 OH OH OH OH 0, " N NNH2 H H la OH NH2 Date Recue/Date Received 2021-03-16 L'invention concerne certains dérivés d'amphotéricine (AmB) caractérisés par une toxicité réduite et une activité antifongique conservée. Certains des dérivés sont des dérivés d'urée en C16 d'AmB. Certains des dérivés sont des désoxy-dérivés en C3, C5, C8, C9, C11, C13 ou C15 d'AmB. Certains des dérivés comprennent des modifications en C3' ou C4' de l'appendice mycosamine d'AmB. L'invention concerne également des procédés de fabrication des dérivés d'AmB de l'invention, des compositions pharmaceutiques comprenant les dérivés d'AmB de l'invention, et des procédés d'utilisation des dérivés d'AmB de l'invention.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2925904C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2925904C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2925904C3</originalsourceid><addsrcrecordid>eNrjZLBy9A3w8A9xDfJ09vRTcFJwAbLCHEM8w1yDFcI9QzwUPH0DgvzDXF0UQjxcgxwDXENDPJ0VPP1cXCN4GFjTEnOKU3mhNDeDvJtriLOHbmpBfnxqcUFicmpeakm8s6ORpZGppYGJszFhFQAysSho</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AMPHOTERICIN B DERIVATIVES WITH IMPROVED THERAPEUTIC INDEX</title><source>esp@cenet</source><creator>UNO, BRICE E ; STRUBLE, JUSTIN ; DAILEY, IAN ; KNAPP, DAVID M ; PALYAM, NAGARJUNA ; BURKE, MARTIN D ; DAVIS, STEPHEN ; GRAY, KAITLYN C ; WANG, PULIN</creator><creatorcontrib>UNO, BRICE E ; STRUBLE, JUSTIN ; DAILEY, IAN ; KNAPP, DAVID M ; PALYAM, NAGARJUNA ; BURKE, MARTIN D ; DAVIS, STEPHEN ; GRAY, KAITLYN C ; WANG, PULIN</creatorcontrib><description>6 ABTRACT Provided are certain derivatives of amphotericin B (AmB) characterized by reduced toxicity and retained anti-fungal activity. Certain of the derivatives are C16 urea derivatives of AmB. Certain of the derivatives are C3, C5, C8, C9, C11, C13, or C15 deoxy derivatives of AmB. Certain of the derivatives include C3' or C4 modifications of the mycosamine appendage of AmB. Also provided are methods of making AmB derivatives of the invention, pharmaceutical compositions comprising AmB derivatives of the invention, and methods of use of AmB derivatives of the invention. OH OH \ 0 HO /Me 0 OH OH OH OH 0, " N NNH2 H H la OH NH2 Date Recue/Date Received 2021-03-16 L'invention concerne certains dérivés d'amphotéricine (AmB) caractérisés par une toxicité réduite et une activité antifongique conservée. Certains des dérivés sont des dérivés d'urée en C16 d'AmB. Certains des dérivés sont des désoxy-dérivés en C3, C5, C8, C9, C11, C13 ou C15 d'AmB. Certains des dérivés comprennent des modifications en C3' ou C4' de l'appendice mycosamine d'AmB. L'invention concerne également des procédés de fabrication des dérivés d'AmB de l'invention, des compositions pharmaceutiques comprenant les dérivés d'AmB de l'invention, et des procédés d'utilisation des dérivés d'AmB de l'invention.</description><language>eng ; fre</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211123&amp;DB=EPODOC&amp;CC=CA&amp;NR=2925904C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211123&amp;DB=EPODOC&amp;CC=CA&amp;NR=2925904C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>UNO, BRICE E</creatorcontrib><creatorcontrib>STRUBLE, JUSTIN</creatorcontrib><creatorcontrib>DAILEY, IAN</creatorcontrib><creatorcontrib>KNAPP, DAVID M</creatorcontrib><creatorcontrib>PALYAM, NAGARJUNA</creatorcontrib><creatorcontrib>BURKE, MARTIN D</creatorcontrib><creatorcontrib>DAVIS, STEPHEN</creatorcontrib><creatorcontrib>GRAY, KAITLYN C</creatorcontrib><creatorcontrib>WANG, PULIN</creatorcontrib><title>AMPHOTERICIN B DERIVATIVES WITH IMPROVED THERAPEUTIC INDEX</title><description>6 ABTRACT Provided are certain derivatives of amphotericin B (AmB) characterized by reduced toxicity and retained anti-fungal activity. Certain of the derivatives are C16 urea derivatives of AmB. Certain of the derivatives are C3, C5, C8, C9, C11, C13, or C15 deoxy derivatives of AmB. Certain of the derivatives include C3' or C4 modifications of the mycosamine appendage of AmB. Also provided are methods of making AmB derivatives of the invention, pharmaceutical compositions comprising AmB derivatives of the invention, and methods of use of AmB derivatives of the invention. OH OH \ 0 HO /Me 0 OH OH OH OH 0, " N NNH2 H H la OH NH2 Date Recue/Date Received 2021-03-16 L'invention concerne certains dérivés d'amphotéricine (AmB) caractérisés par une toxicité réduite et une activité antifongique conservée. Certains des dérivés sont des dérivés d'urée en C16 d'AmB. Certains des dérivés sont des désoxy-dérivés en C3, C5, C8, C9, C11, C13 ou C15 d'AmB. Certains des dérivés comprennent des modifications en C3' ou C4' de l'appendice mycosamine d'AmB. L'invention concerne également des procédés de fabrication des dérivés d'AmB de l'invention, des compositions pharmaceutiques comprenant les dérivés d'AmB de l'invention, et des procédés d'utilisation des dérivés d'AmB de l'invention.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBy9A3w8A9xDfJ09vRTcFJwAbLCHEM8w1yDFcI9QzwUPH0DgvzDXF0UQjxcgxwDXENDPJ0VPP1cXCN4GFjTEnOKU3mhNDeDvJtriLOHbmpBfnxqcUFicmpeakm8s6ORpZGppYGJszFhFQAysSho</recordid><startdate>20211123</startdate><enddate>20211123</enddate><creator>UNO, BRICE E</creator><creator>STRUBLE, JUSTIN</creator><creator>DAILEY, IAN</creator><creator>KNAPP, DAVID M</creator><creator>PALYAM, NAGARJUNA</creator><creator>BURKE, MARTIN D</creator><creator>DAVIS, STEPHEN</creator><creator>GRAY, KAITLYN C</creator><creator>WANG, PULIN</creator><scope>EVB</scope></search><sort><creationdate>20211123</creationdate><title>AMPHOTERICIN B DERIVATIVES WITH IMPROVED THERAPEUTIC INDEX</title><author>UNO, BRICE E ; STRUBLE, JUSTIN ; DAILEY, IAN ; KNAPP, DAVID M ; PALYAM, NAGARJUNA ; BURKE, MARTIN D ; DAVIS, STEPHEN ; GRAY, KAITLYN C ; WANG, PULIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2925904C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>UNO, BRICE E</creatorcontrib><creatorcontrib>STRUBLE, JUSTIN</creatorcontrib><creatorcontrib>DAILEY, IAN</creatorcontrib><creatorcontrib>KNAPP, DAVID M</creatorcontrib><creatorcontrib>PALYAM, NAGARJUNA</creatorcontrib><creatorcontrib>BURKE, MARTIN D</creatorcontrib><creatorcontrib>DAVIS, STEPHEN</creatorcontrib><creatorcontrib>GRAY, KAITLYN C</creatorcontrib><creatorcontrib>WANG, PULIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>UNO, BRICE E</au><au>STRUBLE, JUSTIN</au><au>DAILEY, IAN</au><au>KNAPP, DAVID M</au><au>PALYAM, NAGARJUNA</au><au>BURKE, MARTIN D</au><au>DAVIS, STEPHEN</au><au>GRAY, KAITLYN C</au><au>WANG, PULIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AMPHOTERICIN B DERIVATIVES WITH IMPROVED THERAPEUTIC INDEX</title><date>2021-11-23</date><risdate>2021</risdate><abstract>6 ABTRACT Provided are certain derivatives of amphotericin B (AmB) characterized by reduced toxicity and retained anti-fungal activity. Certain of the derivatives are C16 urea derivatives of AmB. Certain of the derivatives are C3, C5, C8, C9, C11, C13, or C15 deoxy derivatives of AmB. Certain of the derivatives include C3' or C4 modifications of the mycosamine appendage of AmB. Also provided are methods of making AmB derivatives of the invention, pharmaceutical compositions comprising AmB derivatives of the invention, and methods of use of AmB derivatives of the invention. OH OH \ 0 HO /Me 0 OH OH OH OH 0, " N NNH2 H H la OH NH2 Date Recue/Date Received 2021-03-16 L'invention concerne certains dérivés d'amphotéricine (AmB) caractérisés par une toxicité réduite et une activité antifongique conservée. Certains des dérivés sont des dérivés d'urée en C16 d'AmB. Certains des dérivés sont des désoxy-dérivés en C3, C5, C8, C9, C11, C13 ou C15 d'AmB. Certains des dérivés comprennent des modifications en C3' ou C4' de l'appendice mycosamine d'AmB. L'invention concerne également des procédés de fabrication des dérivés d'AmB de l'invention, des compositions pharmaceutiques comprenant les dérivés d'AmB de l'invention, et des procédés d'utilisation des dérivés d'AmB de l'invention.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2925904C
source esp@cenet
subjects CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
title AMPHOTERICIN B DERIVATIVES WITH IMPROVED THERAPEUTIC INDEX
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T08%3A49%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=UNO,%20BRICE%20E&rft.date=2021-11-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2925904C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true